scorecard
  1. Home
  2. Science
  3. Health
  4. news
  5. Why Pfizer's not worried about resistance to its new antiviral

Why Pfizer's not worried about resistance to its new antiviral

Leah Rosenbaum   

Why Pfizer's not worried about resistance to its new antiviral

Hello,

Welcome to Insider Healthcare. I'm healthcare editor Leah Rosenbaum, and today in healthcare news:

If you're new to this newsletter, sign up here. Comments, tips? Email me at lrosenbaum@insider.com or tweet @leah_rosenbaum. Let's get to it...


Resistance is one of the biggest threats to new COVID-19 treatments. Here's why Pfizer's top scientist, Mikael Dolsten, isn't worried it will weaken the pharma giant's new pill.

Check it out>>


Amazon considers offering prescription drugs and lottery tickets in its cashierless grocery stores to boost traffic

See the exclusive now>>


See some of the first 5- to 11-year-old kids get their COVID-19 vaccines

Read more>>


More stories we're reading:


-Leah

READ MORE ARTICLES ON



Popular Right Now



Advertisement